Lv71
5000 积分 2021-07-01 加入
High-Risk Features Associated with Recurrence in Stage I Lung Adenocarcinoma
7个月前
已完结
[Introduction to the 9
7个月前
已完结
[Expert consensus on prevention and treatment of checkpoint inhibitor pneumonitis]
1年前
已完结
Overcoming acquired resistance following osimertinib administration in EGFR-mutant lung adenocarcinoma
1年前
已完结
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
1年前
已完结
[Chinese expert consensus of antibody-drug conjugate toxicity management for breast cancer]
1年前
已完结
驱动基因阳性晚期非小细胞肺癌免疫治疗专家共识(2023版) [Chinese expert consensus on immunotherapy for advanced non-small lung cancer with oncogenic driver mutations (2023 edition)]
1年前
已完结
肿瘤化疗导致的中性粒细胞减少诊治中国专家共识(2023版)
1年前
已完结
Topical Immunotherapy in Alopecia areata: Anamnestic and Clinical Criteria of Prognostic Significance
皖公网安备34019202002308
